Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 25.7% | -11% | 5.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 27.7% | 13.7% | 29.1% | 17% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 27.3% | -13.3% | 38.9% | 7.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -137.9% | -36.4% | -7.3% | -9.7% |
| EPS Diluted | -0.512 | -0.11 | -0.025 | -0.031 |
| % Growth | -365.5% | -347.2% | 20.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |